JACLYN SEREMET: Open Payments
NPI 1083983456 · DYER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$775 in 44 payments from 15 companies in 2025. Trend: 2023 $115 · 2024 $16 · 2025 $775
Food & beverage: $775
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $172 |
| PFIZER INC. | 5 | $96 |
| Lilly USA, LLC | 4 | $90 |
| ABBVIE INC. | 4 | $80 |
| Exact Sciences Corporation | 3 | $63 |
| GlaxoSmithKline, LLC. | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $20 |
Products named: NURTEC ODT, MOUNJARO, Cologuard Collection Kit, TRINTELLIX, QULIPTA, TRELEGY ELLIPTA, FARXIGA, Wegovy.
Industry payments across IN — which companies pay providers there.
